Stéphanie Blanchard

719 citations

29 papers · 548 indexed · h-index 12

Genetics top 10%
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
Hematology top 10%
Oncology
- Cancer-related Molecular Pathways 5
Organic Chemistry top 10%
- Synthesis and Biological Evaluation 6
- Coordination Chemistry and Organometallics 3
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 3
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 3
Cell Biology
- Microtubule and mitosis dynamics 3

Co-authors: Anders Poulsen Kee Chuan Goh Brian Dymock Meredith Williams Anthony D. William Harish Nagaraj Kantharaj Ethirajulu Eric T. Sun
Cited by: Genetics Hematology Oncology
Journals: The Journal of Chemical Physics (1 paper)Journal of Clinical Oncology (3 papers)Blood (1 paper)
Partner nations: Singapore United States France

In The Last Decade

Stéphanie Blanchard

28 papers receiving 533 citations

Peers

Countries citing papers authored by Stéphanie Blanchard

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Blanchard more than expected).

Fields of papers citing papers by Stéphanie Blanchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Blanchard. The network helps show where Stéphanie Blanchard may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stéphanie Blanchard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stéphanie Blanchard Line = papers co-authored together Stéphanie Blanchard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Quantitation of the piezoelectric coefficients of room temperature ionic liquids The Journal of Chemical Physics ·Sunday J. Olusegun,Stéphanie Blanchard,Gary A. Baker,G. J. Blanchard	2025	2
2	Clinical activity of EBC-129, a first-in class, anti N256-glycosylated CEACAM5 and CEACAM6 antibody-drug conjugate (ADC), in patients with pancreatic ductal adenocarcinoma (PDAC) in a phase 1 study. Journal of Clinical Oncology ·Robert W. Lentz,Matthew Chau Hsien Ng,Wei Peng Yong,Funda Meric-Bernstam,Inderjeet Singh,Venkatheshan Srirangam,Julienne Cometa,Stéphanie Blanchard,Ranjani Nellore,Kunal J. Shah,Y.Y. Lee,Chek Shik Lim,Bong Hwa Gan,Allison Tan,Nurul Rozaini,Claudia Koh,Nur Quraishah Adanani,Joe Yeong,V. Diermayr	2025	1
3	653P A phase I dose escalation study of EBC-129, a first-in class, anti N-glycosylated CEACAM5 & CEACAM6 antibody-drug conjugate (ADC) in patients with solid tumors Annals of Oncology ·Matthew Chau Hsien Ng,Wei Peng Yong,F. Meric-Bernstam,Robert W. Lentz,Venkatheshan Srirangam,Julienne Cometa,Stéphanie Blanchard,Ranjani Nellore,Ayça Tan,Y-A. Lee,Joel Louis Lim,S. Gan,Claudia Koh,Q. Adanan,J. Joy,Vishal Pendharkar,Joe Yeong,V. Diermayr	2024	0
4	First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug Clinical and Translational Science ·Vincenzo Teneggi,Veronica Novotny‐Diermayr,Lay Hoon Lee,Maryam Yasin,Pauline Yeo,Kantharaj Ethirajulu,S. Gan,Stéphanie Blanchard,Ranjani Nellore,Dhananjay N. Umrani,Roberto Goméni,Darren Lim Wan Teck,Greg Li,Qing Lu,Yang Cao,Alex Matter	2019	11
5	Phase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours Annals of Oncology ·David S.P. Tan,Matthew Chau Hsien Ng,Vivek Subbiah,Wells A. Messersmith,Vincenzo Teneggi,V. Diermayr,Kantharaj Ethirajulu,Pauline Yeo,Bong Hwa Gan,L.H. Lee,Stéphanie Blanchard,Ranjani Nellore,Maryam Yasin,Dhananjay N. Umrani,M.A. Lee,Jeffrey Hill,Babita Madan,David M. Virshup,A. Matter	2018	12
6	152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours Annals of Oncology ·Vincenzo Teneggi,Matthew Ng,David S.P. Tan,Vivek Subbiah,Colin D. Weekes,V. Diermayr,Kantharaj Ethirajulu,Pauline Yeo,D. Chen,S. Gan,Stéphanie Blanchard,Ranjani Nellore,M.A. Lee,Jeffrey Hill,David M. Virshup,Babita Madan,A. Matter	2016	10
7	Structure and Ligand-Based Design of mTOR and PI3-Kinase Inhibitors Leading to the Clinical Candidates VS-5584 (SB2343) and SB2602 Journal of Chemical Information and Modeling ·Anders Poulsen,Harish Nagaraj,Angeline Lee,Stéphanie Blanchard,Chang Kai Soh,Dizhong Chen,Haishan Wang,Stefan Hart,Kee Chuan Goh,Brian Dymock,Meredith Williams	2014	27
8	Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3) Journal of Molecular Modeling ·Anders Poulsen,Anthony D. William,Stéphanie Blanchard,Harish Nagaraj,Meredith Williams,Haishan Wang,Angeline Lee,Eric T. Sun,Ee-Ling Teo,Evelyn Tan,Kee Chuan Goh,Brian Dymock	2012	29
9	Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3) Journal of Computer-Aided Molecular Design ·Anders Poulsen,Anthony D. William,Stéphanie Blanchard,Angeline Lee,Harish Nagaraj,Haishan Wang,Ee-Ling Teo,Evelyn Tan,Kee Chuan Goh,Brian Dymock	2012	31
10	Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screening Bioorganic & Medicinal Chemistry Letters ·Angeline C.-H. Lee,Pondy Murugappan Ramanujulu,Anders Poulsen,Meredith Williams,Stéphanie Blanchard,Mia Nur Diana,Zahid Bonday,Kay Lin Goh,Kee Chuan Goh,Miah Kiat Goh,Jeanette M. Wood,Brian Dymock	2012	9
11	2-Anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1 Bioorganic & Medicinal Chemistry Letters ·Stéphanie Blanchard,Chang Kai Soh,Chai Ping Lee,Anders Poulsen,Zahid Bonday,Kay Lin Goh,Kee Chuan Goh,Miah Kiat Goh,Mohammad Pasha,Haishan Wang,Meredith Williams,Jeanette M. Wood,Kantharaj Ethirajulu,Brian Dymock	2012	10
12	Structure-based design of PDK1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Anders Poulsen,Stéphanie Blanchard,Chang Kai Soh,Chaiping Lee,Meredith Williams,Haishan Wang,Brian Dymock	2011	11
13	Discovery of Kinase Spectrum Selective Macrocycle (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer Journal of Medicinal Chemistry ·Anthony D. William,Angeline C.-H. Lee,Kee Chuan Goh,Stéphanie Blanchard,Anders Poulsen,Ee Ling Teo,Harish Nagaraj,Chai Ping Lee,Haishan Wang,Meredith Williams,Eric T. Sun,Changyong Hu,Ramesh Jayaraman,Mohammad Pasha,Kantharaj Ethirajulu,Jeanette M. Wood,Brian Dymock	2011	78
14	Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Stéphanie Blanchard,Anthony D. William,Angeline C.-H. Lee,Anders Poulsen,Ee Ling Teo,Weiping Deng,Noah P. Tu,Evelyn Tan,Kay Lin Goh,Wai Chung Ong,Chee Pang Ng,Kee Chuan Goh,Zahid Bonday,Eric T. Sun	2010	15
15	Structure-based design of Aurora A & B inhibitors Journal of Computer-Aided Molecular Design ·Anders Poulsen,Anthony D. William,Angeline Lee,Stéphanie Blanchard,Ee-Ling Teo,Weiping Deng,Noah P. Tu,Evelyn Tan,Eric T. Sun,Kay Lin Goh,Wai Chung Ong,Chee Pang Ng,Kee Chuan Goh,Zahid Bonday	2008	8
16	New Access to Oxazolopyridines via Hydroxyamidine Derivatives: Application to Quinolines. ChemInform ·Ethel Garnier,Stéphanie Blanchard,Ivan Rodriguez,Christian Jarry,Jean‐Michel Léger,P. Caubère,Gérald Guillaumet	2004	1
17	Synthesis of Mono- and Bisdihydrodipyridopyrazines and Assessment of Their DNA Binding and Cytotoxic Properties Journal of Medicinal Chemistry ·Stéphanie Blanchard,Ivan Rodriguez,Christelle Tardy,Brigitte Baldeyrou,Christian Bailly,Pierre Colson,Claude Houssier,Stéphane Léonce,Laurence Kraus‐Berthier,Bruno Pfeiffer,Pierre Renard,Alain St. Pierre,P. Caubère,Gérald Guillaumet	2004	7
18	New Access to Oxazolopyridines via Hydroxyamidine Derivatives; Application to Quinolines Synthesis ·P. Caubère,Gérald Guillaumet,Ethel Garnier,Stéphanie Blanchard,Ivan Rodriguez,Christian Jarry,Jean‐Michel Léger	2003	3
19	Hetarynic synthesis and chemical transformation of dihydrodipyridopyrazines Tetrahedron ·Stéphanie Blanchard,Ivan Rodriguez,Catherine Kuehm‐Caubere,Pierre Renard,Bruno Pfeiffer,Gérald Guillaumet,P. Caubère	2002	14
20	Metalation and Functionalization of Dihydrodipyridopyrazines. ChemInform ·Stéphanie Blanchard,Ivan Rodriguez,P. Caubère,Gérald Guillaumet	2002	1

About Stéphanie Blanchard

Stéphanie Blanchard is a scholar working on Genetics, Oncology and Toxicology, having authored 29 papers that have together received 548 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (6 papers), Cancer-related Molecular Pathways (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Microtubule and mitosis dynamics (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Coordination Chemistry and Organometallics (3 papers). The work is most often cited by research in Genetics (118 citations), Hematology (76 citations) and Oncology (166 citations). Stéphanie Blanchard has collaborated with scholars based in Singapore, United States and France. Frequent co-authors include Anders Poulsen, Kee Chuan Goh, Brian Dymock, Meredith Williams, Anthony D. William, Harish Nagaraj, Kantharaj Ethirajulu, Eric T. Sun, Haishan Wang and Jeanette M. Wood. Their work appears in journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact